WeDaita Platform BioMedAI

Target to Candidate — One Knowledge Platform

An agentic AI platform for drug discovery. We automate complex research workflows by integrating and harnessing the power of AI across the drug discovery pipeline—so scientists can focus on what matters most and accelerate the path to new therapies.

Try BioMedAI Full AI platform Book a Call 30-min consultation
  See It in Action
200+MCP Tools
40+Databases
GraphRAGReasoning
Proprietary AI Models
CLINAVA clinical progression
GENAVA virtual target validation
Integrated Platform

Prediction-Driven Drug Discovery.

From target selection to patient advancement — guided by clinical progression intelligence at every stage.

Three specialized agent systems, each designed to reduce attrition at its stage and feed higher-confidence decisions into the next.

Stage 1 — Early Research
DBRA
Deep Biomedical Research Agents
2 Agents Live
Solves the Haystack Problem — automating evidence synthesis to generate and validate novel drug targets — in hours, not months.
  • Deep Research on drug research
  • Disease-to-target hypothesis generation
  • Drug Target PrioritizationIn Dev
  • Drug RepurposingIn Dev
Focus
Stage 2 — Drug Design
ADDA
Autonomous Drug Design Agents
1 Agent Live
Bridges the Translation Gap — automating biologic and small molecule drug design to reduce preclinical failure rates.
  • Protein / antibody drug design
  • Peptide/MacrocycleIn Dev
  • Small molecule design & optimisationIn Dev
Focus
Stage 3 — Clinical Trials
CTIA
Clinical Trial Intelligence Agents
Addresses Late-Stage Attrition — AI-assisted protocol design, predictive recruitment, and portfolio optimization.
  • Digital twin trial simulationRoadmap
  • Predictive patient recruitmentRoadmap
  • AI-assisted protocol designRoadmap
  • Portfolio optimizationRoadmap
Focus

Experience AI-Powered Drug Discovery

Watch our autonomous AI Scientists platform accelerate research from months to minutes

  • Real-time demonstration of AI agents in action
  • Target identification in minutes, not months
  • Comprehensive insights from 11 biomedical databases
  • Autonomous research with zero human intervention
AI RESEARCH INTELLIGENCE

Research Digest

AI-curated papers, FDA approvals, clinical compounds, and disclosures from drug discovery's leading sources — scored for relevance by the WeDaita AI agent every week.

Explore Research Digest
Target Identification
GWAS associations, CRISPR screen hits, druggability assessments
Peer-reviewed evidence and industry pipeline news on novel drug targets, scored for translational relevance.
Drug Design
FDA approvals, clinical compounds, molecular disclosures, patents
AI molecular generation, openFDA NDA approvals, ChEMBL Phase I–III candidates, and Drug Hunter patent roundups.
Clinical Trials
Active trials, regulatory milestones, trial methodology
ClinicalTrials.gov updates, FDA and EMA designations, IND filings, and patient stratification research.
3Topics
WeeklyUpdates
WeDaita AIRelevance Scoring
6+Data Sources
Latest from WeDaita

News & Blog

Company updates, tutorials, and community posts — all in one place.

No blog posts yet.

All Blog Posts
Stay Ahead

AI Drug Discovery, Delivered Monthly

Get curated insights on AI-driven target identification, therapeutic design, and BioMedAI platform updates — directly to your inbox.

No spam. Unsubscribe at any time. We respect your privacy.

Built by People Who've Lived the Problem

The Team Behind BioMedAI

Scientists, engineers, and domain experts united by one mission — making drug discovery faster and smarter.

Leadership Team
Scientific Experts
All Members  
The Validation

Ecosystem Recognition & Strategic Support

Selected by leading innovation programs supporting AI and life sciences.

NVIDIA Inception Program

Member of NVIDIA’s global startup program accelerating AI innovation — providing access to the NVIDIA AI ecosystem, technical resources, and industry connections.

awsActivate

Qualified for AWS startup support, cloud credits, and infrastructure resources to accelerate scalable AI platform development.

Harvard Business School Foundry

Selected for entrepreneurial support and founder ecosystem access through Harvard Business School’s innovation programs.

Grounded in Primary Scientific Sources

Every insight traces back to 41 primary databases (PubMed, UniProt, ChEMBL, PDB, and more) and 173 scientific tools — not black-box outputs.

Built by Drug Discovery Scientists

Our team has decades of combined experience in computational biology, medicinal chemistry, and AI research.

Researcher in the Loop, Always

BioMedAI accelerates your thinking — your scientific judgement drives every key decision.

Ready to Accelerate Your Drug Discovery?

BioMedAI is live — start with target identification and protein drug design today, with more modules launching soon.

  Try BioMedAI   Book a Demo